Gregory Brown

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when Lisata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get LSTA alerts

About Gregory Brown

Gregory Brown is recorded as Chairman at Lisata Therapeutics, Inc. (LSTA) since September 15, 2022. Lisata Therapeutics, Inc. reported in an 8-K filed September 15, 2022 that Gregory Brown was appointed Chairman, effective September 15, 2022. Lisata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lisata Therapeutics, Inc. includes David J. Mazzo (CEO and Board Member), David J. Mazzo, Ph.D. (CEO), Gregory Brown, M.D. (Chairman) and 7 others.

“Gregory Brown, M.D., former Chairman of Caladrius, will continue in the role as Chairman of Lisata”

Lisata Therapeutics, Inc. Form 8-K, filed September 15, 2022 · Read the filing

Affiliation history

Lisata Therapeutics, Inc. (LSTA)
Chairman

SEC 8-K

Current
2022-09-15–present

Company network

Lisata Therapeutics, Inc.

LSTA

Current role

Biotechnology · Healthcare

Chairman

2022-09-15–present

Leadership on record at Lisata Therapeutics, Inc.

David J. Mazzo CEO, Board Member
David J. Mazzo, Ph.D. CEO
Gregory Brown, M.D. Chairman
Dr. Josh Lehrer COO
Josh Lehrer COO
Josh Lehrer, M.D., M.Phil., FACC COO
Tariq Imam General Counsel
James Nisco Chief Accounting Officer
Anne Whitaker Board Member
CLASS I Board Member

Recent activity

Executive change Appointed: Chairman Lisata Therapeutics, Inc. (LSTA)
2022-09-15